
Gene-based treatment of drug-resistant patients with Schizophrenia 217
Vol. 65(2): 206 - 219, 2024
ture review, performed statistical analysis,
and assisted in manuscript revisions; M.Z as-
sisted in data collection and participated in
data analysis and J.H supervised the study,
contributed to data analysis and interpreta-
tion, and provided overall guidance in manu-
script preparation.
REFERENCES
1. Yan Y, Qifeng D, Daiwei Z, Haiping Z. A
random control trial of group psychologi
-
cal crisis intervention on defensive style
and anxiety for the first-degree relatives of
patients with schizophrenia. Chinese Ment
Heal J. 2021;35(6):466-471.
2. Xiong H, Zhang H, Chen X, Cheng Y,
Huang C. Clinical characteristics and rela
-
ted factors of pneumonia in patients with
aplastic anemia. Chinese J Infect Che
-
mother. 2019;19(1):27-31. https://doi.org
/10.16718/j.1009-7708.2019.01.006
3. Green MF, Horan WP, Lee J, McCleery,
Reddy L F, Wynn JK. Social discon
-
nection in schizophrenia and the ge-
neral community. Schizophrenia bulle-
tin. 2018;44(2):242-249. https://doi.
org/10.1093/schbul/sbx082
4. Barut JK, Dietrich MS, Zanoni PA, Ridner
SH. Sense of belonging and hope in the lives
of persons with schizophrenia. Arch Psych
Nursing. 2016;30(2):178-184. https://
doi.org/10.1016/j.apnu.2015.08.009
5. Ying J, Jue L, Minghuan Z, Zuo H, Dian
-
hong S, Jia L. Comparison of efficacy and
safety between sodium valproate and mo
-
dified electroconvulsive therapy in cloza-
pine-resistant refractory schizophrenia. J
Tongji Univ Medical Sci. 2022;43(2):388-
393.
6. Xu QW, Liu X, Yao QK, Zheng ZJ. CYP co
-
rrelation study of refractory s c h i -
zophrenia drug gene detection. J Hainan
Med Coll. 2019;25(5).
7. Kane M. CYP2D6 overview: allele and
phenotype frequencies. Medical Genetics
Summaries [Internet]: National Center
for Biotechnology Information (US); 2021.
8. Pouget JG, Shams TA, Tiwari AK, Müller
DJ. Pharmacogenetics and outcome with
antipsychotic drugs. Dialogues Clin Neu
-
rosci. 2014;16(4):555-566. https://doi.
org/10.31887/DCNS.2014.16.4/jpouget
9. Zanello A, Berthoud L, Ventura J, Mer
-
lo MC. The Brief Psychiatric Rating Sca-
le (version 4.0) factorial structure and
its sensitivity in the treatment of outpa
-
tients with unipolar depression. Psychiatry
Res. 2013;210(2):626-633. https://doi.
org/10.1016/j.psychres.2013.07.001
10. Depp CA, Loughran C, Vahia I, Molinari
V. Chapter 5 - Assessing Psychosis in Acu
-
te and Chronic Mentally Ill Older Adults.
In: Lichtenberg PA, editor. Handbook of
Assessment in Clinical Gerontology (Se
-
cond Edition). San Diego: Academic Press;
2010. p. 123-54. https://doi.org/10.1016/
B978-0-12-374961-1.10005-3
11. Edemekong PF, Bomgaars DL, Sukuma
-
ran S, Schoo C. Activities of Daily Living.
StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing; 2023 Jan. 2023 Jun
26. [PubMed ID: 29261878].
12. Yu W, Tong J, Sun X, Chen F, Zhang
J, Pei Y, Zhang T, Zhang J, Zhu B.
Analysis of medication adherence and its
influencing factors in patients with
schizophrenia in the Chinese Institutio
-
nal Environment. Int J Environ Res and
public health. 2021;18(9). https://doi.
org/10.3390/ijerph18094746
13. Yun F, Yanfang Z, Xuehao W, Jinghui T,
Mengzhuang G, Fude Y, Baopeng T, Yun
-
long T. Allostatic load and its relationship
with cognitive deficits in patients with
first-episode schizophrenia. Chinese Ment
Heal J. 2021;35(10):814-819.
14. Patel KR, Cherian J, Gohil K, Atkinson D.
Schizophrenia: overview and treatment op
-
tions. P & T: a peer-reviewed journal for for-
mulary management. 2014;39(9):638-645.
15. Zhi L, Qinfang B, Ning L, Fangbin C, Ying
C, Xiaoyan W, Falin Q, Pharmaceutical care
in 3 Patients with cchizophrenia created
with clozapine. Her Med. 2021;40(5):674-
677. https://doi.org/10.3870/j.issn.1004-
0781.2021.05.019
16. Guo-qin H, Qin-yu L, Jing Z, Ming-huan
Z, Shun-ying Y, Zheng-hui Y, Jian C. As
-
sociation study of non-coding variant